The listing below shows our latest News Items and is updated regularly. If you wish to post a news item please select the 'Post News' button on the right. The displayed news feed starts on 1st August 2016. Older items can be found here.
To 'Post Your News' use the button at the top right.
Birmingham & London, UK - SRG has appointed Marianna Suckova as Director of Clinical, based in London. Marianna Suckova brings extensive knowledge of Drug Development along with a notable pedigree in sales activities, recruitment, change management and people leadership.
Read the rest of entry »
Birmingham & Newcastle, UK - Science, clinical and engineering recruiter SRG has expanded its Newcastle office with the addition of two new recruiters. Joining the team are Associate Consultants Richard McDermott and Luke Argent, who arrive in response to growing demand for specialist recruitment services in the North East.
Oxford, UK – Glide Technologies, the pharmaceutical development and device company focused on the needle-free administration of solid dose formulations, today announced the successful completion of a funding round totalling £3.2 million ($4.0 million). The fundraising was supported by a number of existing investors.
Abingdon, UK - OBN, the membership organisation supporting the UK’s innovative life sciences companies is pleased to announce today that Venner Shipley, a leading firm of European patent & trade mark attorneys and IP lawyers, has become OBN’s exclusive patent and trade mark attorney sponsor.
Harwell, UK - The Electrospinning Company, announces that it has secured a £650,000 investment to establish itself as the leading provider of clinical-grade electrospun biomaterials to the medical device industry. Funding has come from a network of UK angel investors, including Angels 5K, LBA, Minerva, Wroxall, Angels in MedCity and OION, as well as from the Rainbow Seed Fund.
Oxford, UK & Bagsværd, Denmark - University of Oxford and Novo Nordisk today announced a landmark research collaboration focused on type 2 diabetes. The partnership will enable scientists from Novo Nordisk and University of Oxford to collaborate to discover innovative approaches for treating type 2 diabetes. As part of the collaboration, Novo Nordisk is also investing in a new research centre on the premises of the University of Oxford.
Alexandria & San Jose, USA and Oxford, UK – Oxford Finance LLC, an industry-leading specialty finance firm that provides senior debt to life sciences and healthcare services companies, today announced the closing of a $10 million senior secured term loan with Oxford BioTherapeutics (“OBT”), an international, clinical-stage biotechnology company focused on developing antibody-based therapies to treat cancer.
London, UK - Tests including an ultrasonic hologram and treatments for serious conditions, such as hospital superbugs, are the latest projects to win a share of Government funding. Sixty seven projects will win a share of £26 million funding available through Biomedical Catalyst 2016, which is run by Innovate UK and the Medical Research Council, and aims to develop innovative healthcare technologies and processes.
Cambridge, UK – Cresset, innovative provider of software and contract research services for small molecule discovery and design, is pleased to announce a corporate rebrand, reflecting a new structure for this growing business.
Gosport, UK - Wickham Laboratories Ltd is pleased to provide the results of our case study on the bioburden of the new polymer £5 note.
OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.
This is an impromptu noticeboard to let people know about events, other things that are happening, perhaps lab equipment for sale etc. Just drop an email to us, email@example.com, and we will post.